Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;78(11):4589-92.
doi: 10.1128/IAI.00705-10. Epub 2010 Aug 9.

Specific and nonspecific B-cell function in the small intestines of patients with Whipple's disease

Affiliations

Specific and nonspecific B-cell function in the small intestines of patients with Whipple's disease

Anika Geelhaar et al. Infect Immun. 2010 Nov.

Abstract

Whipple's disease is a chronic multisystemic infection caused by Tropheryma whipplei that is characterized by arthritis, weight loss, and diarrhea. The immunological defects in the duodenal mucosa, the site of major replication of the agent underlying the pathogenesis of Whipple's disease, are poorly understood. Mucosal immunoglobulins are essential for the defense against intestinal pathogens; therefore, we analyzed the B-cell response in duodenal specimens and sera of Whipple's disease patients. Whereas systemic immunoglobulin production was affected only marginally, duodenal biopsy specimens of Whipple's disease patients contained reduced numbers of immunoglobulin-positive plasma cells and secreted less immunoglobulin compared to healthy controls but showed a weak secretory IgA response toward T. whipplei. This T. whipplei-specific intestinal immune response was not observed in controls. Thus, we were able to demonstrate that general mucosal immunoglobulin production in Whipple's disease patients is impaired. However, this deficiency does not completely abolish T. whipplei-specific secretory IgA production that nonetheless does not protect from chronic infection.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Immunoglobulin production in duodenal biopsy specimens of Whipple's disease patients compared to healthy subjects, as evidenced by exemplary immunostaining of IgA (colored in red). (A) High number of IgA+ plasma cells in a healthy control; (B and C) low number of IgA+ plasma cells in a Whipple's disease patient before the start of treatment (B) and in the same Whipple's disease patient after 6 months of antimicrobial treatment (C).
FIG. 2.
FIG. 2.
Percentage of immunoglobulin-producing plasma cells among all plasma cells in duodenal biopsy specimens from Whipple's disease (WD) patients and healthy controls as determined by immunohistochemistry. (A) Percentage of IgA+ plasma cells; (B) percentage of IgG+ plasma cells; (C) percentage of IgM+ plasma cells. Individual values, medians, and interquartile ranges are shown, and P values were determined by using the Mann-Whitney test.
FIG. 3.
FIG. 3.
Immunoglobulin concentrations in supernatants of duodenal biopsy specimens obtained from healthy subjects and Whipple's disease patients during or after antimicrobial treatment. (A) IgA; (B) IgG2; (C) IgM. Individual values, medians, and interquartile ranges are shown, and P values were determined by using the Mann-Whitney test. WD, Whipple's disease.
FIG. 4.
FIG. 4.
Western blot for T. whipplei-specific immunoglobulins. Exemplary Western blots of T. whipplei-specific IgA (lane 1) and IgG (lane 2) in the serum from a Whipple's disease (WD) patient (positive control), secretory IgA in biopsy specimen supernatants from three healthy controls (lanes 3 to 5), and secretory IgA in biopsy specimen supernatants from three Whipple's disease patients (lanes 6 to 8). Arrowheads indicate T. whipplei-antigens recognized by the respective supernatants and sera used as positive controls. C1 to C3, healthy subjects; WD1 to WD3, Whipple's disease patients.

Similar articles

Cited by

References

    1. Bonhomme, C. J., P. Renesto, B. Desnues, E. Ghigo, H. Lepidi, P. Fourquet, F. Fenollar, B. Henrissat, J. L. Mege, and D. Raoult. 2009. Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease. J. Infect. Dis. 199:1043-1052. - PubMed
    1. Bonhomme, C. J., P. Renesto, S. Nandi, A. M. Lynn, and D. Raoult. 2008. Serological microarray for a paradoxical diagnostic of Whipple's disease. Eur. J. Clin. Microbiol. Infect. Dis. 27:959-968. - PubMed
    1. Desnues, B., H. Lepidi, D. Raoult, and J. L. Mege. 2005. Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J. Infect. Dis. 192:1642-1646. - PubMed
    1. Ectors, N., K. Geboes, R. De Vos, H. Heidbuchel, P. Rutgeerts, V. Desmet, and G. Vantrappen. 1992. Whipple's disease: a histological, immunocytochemical, and electron microscopic study of the immune response in the small intestinal mucosa. Histopathology 21:1-12. - PubMed
    1. Fenollar, F., B. Amphoux, and D. Raoult. 2009. A paradoxical Tropheryma whipplei Western blot differentiates patients with Whipple disease from asymptomatic carriers. Clin. Infect. Dis. 49:717-723. - PubMed

Publication types

MeSH terms

LinkOut - more resources